1-(5-(4-氨基-7-甲基-7H-吡咯并[2,3-d]嘧啶-5-基)二氢吲哚-1-基)-2-(3-(三氟甲基)苯基)乙酮
1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone;GSK2606414 (Synonyms: GSK 2606414)
ChemLeader
产品编号:
CAS No.:
MDLNo:
分子式:
分子量:
选择规格
20 mg 50 mg 100 mg
产品库存
In-stock
目录价格
¥520.00
会员价格
产品库存
In-stock
目录价格
¥850.00
会员价格
产品库存
In-stock
目录价格
¥1450.00
会员价格
选择数量
- +
基本信息
中文名称1-(5-(4-氨基-7-甲基-7H-吡咯并[2,3-d]嘧啶-5-基)二氢吲哚-1-基)-2-(3-(三氟甲基)苯基)乙酮
英文名称 1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone;GSK2606414 (Synonyms: GSK 2606414)
CAS号1337531-36-8
分子式C24H20F3N5O
分子量451.44
外观White powder
储存条件 Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
安全信息
产品详情

GSK2606414 is an orally available, selective protein kinase R-like ER kinase (PERK) inhibitor with an IC50 value of 0.4 nM. It can inhibit thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells and attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Because PERK mediates the unfolded protein response pathway, which has roles in neurotoxicity and cancer, inhibition of PERK signaling has potential applications for the treatment of cancer and also cognitive degeneration.


相关文献
相关产品
抱歉,暂时没有相关产品
浏览记录
1-(5-(4-氨基-7-甲基-7H-吡咯并[2,3-d]嘧啶-5-基)二氢吲哚-1-基)-2-(3-(三氟甲基)苯基)乙酮